U.S. Prostate Cancer Treatment Devices Market to Witness Robust Growth in Coming Years

The surging prevalence of prostate cancer, mounting geriatric population, and soaring number of government initiatives are expected to drive the U.S. prostate cancer treatment devices market at a CAGR of 5.6% during the forecast period (2020–2030). The market stood at $95.9 million in 2019, and it is projected to reach $157.1 million by 2030. Moreover, the updations in treatment protocols and technological developments in medical devices will also support the market growth in the coming years.

Receive Sample Pages of this Report: https://www.psmarketresearch.com/market-analysis/us-prostate-cancer-treatment-device-market-revenue/report-sample

The U.S. prostate cancer treatment devices market growth is driven by the surging incidence of prostate cancer in the country. The Centers for Disease Control and Prevention (CDC) says that prostate cancer is the most-prevalent cancer among the male residents of the country after non-melanoma skin cancer. It is also one of the major causes of cancer deaths among American men. Further, the American Cancer Society (ACS) estimates that the country will record 248,530 new cases of prostate cancer and 34,130 deaths from it in 2021.

Make an Enquiry Before Purchase: https://www.psmarketresearch.com/send-enquiry?enquiry-url=us-prostate-cancer-treatment-device-market-revenue

The type segment of the U.S. prostate cancer treatment devices market is categorized into HIFU, radiation, cryotherapy, and surgery. In 2019, the radiation category generated the highest revenue owing to the high availability of radiation therapy devices, presence of numerous market players, and significant deployment of these systems. Furthermore, the category is also expected to demonstrate the fastest growth during the forecast period, primarily on account of the high acceptance and adoption of radiotherapy and the introduction of advanced equipment.

According to P&S Intelligence, California accounted for the largest share in the U.S. prostate cancer treatment devices market in 2019, and it is expected to maintain the lead throughout the forecast period. This can be ascribed to the burgeoning cases of prostate cancer, soaring number of hospitals and specialty care centers, and rising availability of advanced treatment equipment in the state. According to the ACS, California is expected to record around 187,140 new cases of prostate cancer and nearly 61,860 related deaths in 2021.

About P&S Intelligence
P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com

This release was published on openPR.